Weight Loss
Magenstrasse and Mill procedure combined with Roux-en-Y gastric bypass improves weight loss
Published in Obesity and Diabetes Week, September 11th, 2006
According to a study from England, "The Magenstrasse and Mill operation (M&M) is effective in producing sustained weight loss and reducing obesity-related comorbidity. It avoids the implantation of foreign material and is a more physiological procedure by maintaining normal gastric emptying. Side-effects are minimal and operative mortality is low. Satisfactory weight loss is seen at 1 year with 60% of excess weight lost. The present study compared weight loss produced by the combination of a Roux-en-Y gastric bypass (RYGBP) with the standard...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Diabetes & Obesity
Chromium (D-Phenylalanine)3 shows insulin-sensitizing and cholesterol-lowering effects - Diabetes Therapy
Glucagon-like peptide-1 analog improves glucose tolerance in obese diabetic mice - Obesity Risk Factors
Insulin resistance impacts risk for obesity-related metabolic comorbidities in adolescents - Obesity Therapy
Sibutramine plus behavior therapy program reduced BMI and body weight in obese adolescents - Adipose Tissue
Adipose cells functions and proliferations may be regulated by varying immunological mechanism - Adipose Tissue
Tumor necrosis factor-alpha and interleukin-1 beta raise CTRP1 expression in adipose tissue - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
